Marksans Pharma Stock Sees Positive Trend, Outperforms Sector by 4.99% on November 12, 2024
On November 12, 2024, midcap pharmaceutical company Marksans Pharma's stock showed a positive trend, gaining 6.35% and outperforming the sector by 4.99%. This follows two days of decline, suggesting a possible reversal. The stock also reached an intraday high of Rs 304 and is currently trading above its moving averages. According to MarketsMojo, the stock call is 'Hold'. In comparison to the market, Marksans Pharma has outperformed the Sensex by 6.82% in one day and 8.81% in the past month. This article presents factual information and does not offer any future potential, investor interest, or expert opinions. It is for informational purposes only and not a recommendation to buy or sell the stock. Investors should conduct their own research and seek advice from a financial advisor before making any investment decisions.
Marksans Pharma, a midcap pharmaceutical company, saw a positive trend in its stock performance on November 12, 2024. The stock gained 6.35% on this day, outperforming the sector by 4.99%. This comes after two consecutive days of fall, indicating a possible trend reversal.
The stock also touched an intraday high of Rs 304, showing a 5.21% increase. Marksans Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the stock call for Marksans Pharma is 'Hold'. This means that investors should hold onto their current positions in the company's stock.
In comparison to the overall market performance, Marksans Pharma has outperformed the Sensex by 6.82% in just one day. In the past month, the stock has also outperformed the Sensex by 8.81%.
It is important to note that this article is based on factual information and does not include any future potential, investor interest, or expert opinions. This is purely for informational purposes and does not serve as a recommendation to buy or sell the stock. Investors are advised to do their own research and consult with a financial advisor before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
